N<sup>6</sup>-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis
Hao Zheng(Hunan Normal University), Yuan Yang(Shanghai Third People's Hospital), Yuan‐Ping Tao(Ministry of Education), Daimin Xiang(Second Military Medical University), Zhangjun Cheng(Zhongda Hospital Southeast University), Weiping Zhou(Shenyang Medical College), Bo Liang(Nanchang University), Le Yang(Guangzhou University of Chinese Medicine), Takumi Kawaguchi(Kurume University), Shengyu Huang(Tongji University), Jennifer D. Wu(Chang Gung University), Hrishikesh Samant(Louisiana State University Health Sciences Center Shreveport), Huifen Li(Beijing University of Chemical Technology), Shengxian Yuan(Second Military Medical University), Zhenguang Wang(Shanghai Third People's Hospital), Jun-sheng Ni(Shanghai Third People's Hospital)
Cited by 32
Related Papers
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410